catalyst
as of 2026-07-01A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Pa — primary completion
at a glance
2009-06 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.
Event
What
A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Pa — primary completion
Type
Trial Readout
Date
2009-06
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here